Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility--an open-label, 6-week study.
about
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.Wearing-off scales in Parkinson's disease: critique and recommendations.Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review.
P2860
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility--an open-label, 6-week study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Direct switch from levodopa/be ...... --an open-label, 6-week study.
@en
Direct switch from levodopa/be ...... --an open-label, 6-week study.
@nl
type
label
Direct switch from levodopa/be ...... --an open-label, 6-week study.
@en
Direct switch from levodopa/be ...... --an open-label, 6-week study.
@nl
prefLabel
Direct switch from levodopa/be ...... --an open-label, 6-week study.
@en
Direct switch from levodopa/be ...... --an open-label, 6-week study.
@nl
P2093
P1476
Direct switch from levodopa/be ...... y--an open-label, 6-week study
@en
P2093
Helena Nissinen
Karla Eggert
Khaled Amar
Liisa Luotonen
Mika Leinonen
Mikko Kuoppamäki
Wolfgang Oertel
P2888
P304
P356
10.1007/S00702-009-0344-4
P577
2009-12-15T00:00:00Z